Shriram Nallamshetty, MD

Clinical Associate Professor (Affiliated), Medicine - Med/Cardiovascular Medicine Staff, Medicine - Med/Cardiovascular Medicine

Clinical Focus

Cardiovascular Disease

Administrative Appointments

Chief Resident, Medicine Residency Program (2005 - 2006)

Honors & Awards

Professionalism Award, Stanford Medicine Residency Program (2004)

Education & Certifications

Fellowship: Massachusetts General Hospital Cardiology Fellowship (2013) MA
Fellowship: Brigham and Women's Hospital Harvard Medical School (2014) MA
Residency: Stanford University Medical Center (2006) CA
Internship: Stanford University Medical Center (2003) CA
Medical Education: Duke University School of Medicine (2002) NC
Board Certification: American Board of Internal Medicine, Cardiovascular Disease (2009)
BA, Columbia College, NY, Biology (1997)
Board Certification: American Board of Internal Medicine, Internal Medicine (2005)
MD, Duke Univ School of Medicine, Medicine (2002)
Residency, Stanford Univ Medical Center, Medicine (2005)

Contact

sn3@stanford.edu

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

VA Palo Alto Health Care System 3801 Miranda Ave MC 112 Palo Alto CA 94304 Tel: (650) 617-2732 Fax: (650) 614-8473

Additional Clinical Info

Stanford Health Care

All Publications

Profiles With Related Publications

close
Helen M. Blau

Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Research Interests
Prof. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.

306 Total Publications
close
Patrick O. Brown

Professor of Biochemistry, Emeritus
Research Interests
Dr. Brown's research focuses on replacing humanity's most destructive invention - the use of animals as a food technology - by developing a new and better way to produce the world's most delicious, nutritious and affordable meats, fish and dairy foods directly from plants. He is also working on developing and scaling optimal methods for restoring healthy ecosystems and sequestering carbon on the 45% of Earth's surface that have been devastated by animal agriculture.

320 Total Publications
close
Michele Calos

Professor of Genetics, Emerita
Research Interests
My lab is developing innovative gene and stem cell therapies for genetic diseases, with a focus on gene therapy and regenerative medicine.

We have created novel methods for inserting therapeutic genes into the chromosomes at specific places by using homologous recombination and recombinase enzymes.

We are working on 3 forms of muscular dystrophy.

We created induced pluripotent stem cells from patient fibroblasts, added therapeutic genes, differentiated, and engrafted the cells.

134 Total Publications
close
Leslie Chan

Ph.D. Student in Immunology, admitted Autumn 2020

4 Total Publications
close
Ian Y Chen, MD, PhD

Assistant Professor of Medicine (Cardiovascular) and of Radiology (Veterans Affairs)

64 Total Publications
close
Jesse Engreitz

Assistant Professor of Genetics
Research Interests
Regulatory elements in the human genome harbor thousands of genetic risk variants for common diseases and could reveal targets for therapeutics — if only we could map the complex regulatory wiring that connects 2 million regulatory elements with 21,000 genes in thousands of cell types in the human body.

We combine experimental and computational genomics, biochemistry, molecular biology, and genetics to assemble regulatory maps of the human genome and uncover biological mechanisms of disease.

75 Total Publications
close
Alexandra Gordon

Clinical Assistant Professor, Emergency Medicine
Clinical Focus
Critical Care, Critical Care Medicine

32 Total Publications
close
Fumiaki Ikeno

Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine

144 Total Publications
close
Minkyung Kang

Postdoctoral Scholar, Neurosurgery

1 Total Publications
close
Mark A. Kay, M.D., Ph.D.

Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Research Interests
Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.

462 Total Publications
close
Paul A. Khavari, MD, PhD

Carl J. Herzog Professor of Dermatology in the School of Medicine
Clinical Focus
Cancer > Cutaneous (Dermatologic) Oncology, Dermatology, General Dermatology
Research Interests
We work in epithelial tissue as a model system to study stem cell biology, cancer and new molecular therapeutics. Epithelia cover external and internal body surfaces and undergo constant self-renewal while responding to diverse environmental stimuli. Epithelial homeostasis precisely balances stem cell-sustained proliferation and differentiation-associated cell death, a balance which is lost in many human diseases, including cancer, 90% of which arise in epithelial tissues.

233 Total Publications
close
Seung K. Kim M.D., Ph.D.

KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)
Research Interests
We study the development of pancreatic islet cells using molecular, embryologic and genetic methods in several model systems, including mice, pigs, human pancreas, embryonic stem cells, and Drosophila. Our work suggests that critical factors required for islet development are also needed to maintain essential functions of the mature islet. These approaches have informed efforts to generate replacement islets from renewable sources for diabetes.

89 Total Publications